375 related articles for article (PubMed ID: 28411509)
1. Direct-acting antivirals and host-targeting strategies to combat enterovirus infections.
Bauer L; Lyoo H; van der Schaar HM; Strating JR; van Kuppeveld FJ
Curr Opin Virol; 2017 Jun; 24():1-8. PubMed ID: 28411509
[TBL] [Abstract][Full Text] [Related]
2. Antiviral Peptides Targeting the Helicase Activity of Enterovirus Nonstructural Protein 2C.
Fang Y; Wang C; Wang C; Yang R; Bai P; Zhang XY; Kong J; Yin L; Qiu Y; Zhou X
J Virol; 2021 May; 95(12):. PubMed ID: 33789997
[TBL] [Abstract][Full Text] [Related]
3. Antivirals blocking entry of enteroviruses and therapeutic potential.
Anasir MI; Zarif F; Poh CL
J Biomed Sci; 2021 Jan; 28(1):10. PubMed ID: 33451326
[TBL] [Abstract][Full Text] [Related]
4. Antiviral Combination Approach as a Perspective to Combat Enterovirus Infections.
Galabov AS; Nikolova I; Vassileva-Pencheva R; Stoyanova A
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(2):91-9. PubMed ID: 27442375
[TBL] [Abstract][Full Text] [Related]
5. Combating enterovirus replication: state-of-the-art on antiviral research.
Thibaut HJ; De Palma AM; Neyts J
Biochem Pharmacol; 2012 Jan; 83(2):185-92. PubMed ID: 21889497
[TBL] [Abstract][Full Text] [Related]
6. Doxycycline inhibits neurotropic enterovirus proliferation in vitro.
Chi F; Liu X; Li J; Guo M; Zhang Z; Zhou H; Carr MJ; Li Y; Shi W
Virus Res; 2024 Jul; 345():199388. PubMed ID: 38714218
[TBL] [Abstract][Full Text] [Related]
7. Uncovering oxysterol-binding protein (OSBP) as a target of the anti-enteroviral compound TTP-8307.
Albulescu L; Bigay J; Biswas B; Weber-Boyvat M; Dorobantu CM; Delang L; van der Schaar HM; Jung YS; Neyts J; Olkkonen VM; van Kuppeveld FJM; Strating JRPM
Antiviral Res; 2017 Apr; 140():37-44. PubMed ID: 28088354
[TBL] [Abstract][Full Text] [Related]
8. Viral engagement with host receptors blocked by a novel class of tryptophan dendrimers that targets the 5-fold-axis of the enterovirus-A71 capsid.
Sun L; Lee H; Thibaut HJ; Lanko K; Rivero-Buceta E; Bator C; Martinez-Gualda B; Dallmeier K; Delang L; Leyssen P; Gago F; San-Félix A; Hafenstein S; Mirabelli C; Neyts J
PLoS Pathog; 2019 May; 15(5):e1007760. PubMed ID: 31071193
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant Sertraline Is a Broad-Spectrum Inhibitor of Enteroviruses Targeting Viral Entry through Neutralization of Endolysosomal Acidification.
Tseng KC; Hsu BY; Ling P; Lu WW; Lin CW; Kung SH
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062313
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of viral capsid inhibitors in human enterovirus infection and associated diseases.
Li C; Wang H; Shih SR; Chen TC; Li ML
Curr Med Chem; 2007; 14(8):847-56. PubMed ID: 17430140
[TBL] [Abstract][Full Text] [Related]
11. Assessing
Lanko K; Shi C; Patil S; Delang L; Matthijnssens J; Mirabelli C; Neyts J
ACS Infect Dis; 2021 Oct; 7(10):2801-2806. PubMed ID: 34529400
[TBL] [Abstract][Full Text] [Related]
12. Characterization of three small molecule inhibitors of enterovirus 71 identified from screening of a library of natural products.
Li G; Gao Q; Yuan S; Wang L; Altmeyer R; Lan K; Yin F; Zou G
Antiviral Res; 2017 Jul; 143():85-96. PubMed ID: 28412182
[TBL] [Abstract][Full Text] [Related]
13. Selective human enterovirus and rhinovirus inhibitors: An overview of capsid-binding and protease-inhibiting molecules.
Shih SR; Chen SJ; Hakimelahi GH; Liu HJ; Tseng CT; Shia KS
Med Res Rev; 2004 Jul; 24(4):449-74. PubMed ID: 15170592
[TBL] [Abstract][Full Text] [Related]
14. Antiviral therapy for enteroviruses and rhinoviruses.
Rotbart HA
Antivir Chem Chemother; 2000 Jul; 11(4):261-71. PubMed ID: 10950388
[TBL] [Abstract][Full Text] [Related]
15. Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2C.
Bauer L; Manganaro R; Zonsics B; Hurdiss DL; Zwaagstra M; Donselaar T; Welter NGE; van Kleef RGDM; Lopez ML; Bevilacqua F; Raman T; Ferla S; Bassetto M; Neyts J; Strating JRPM; Westerink RHS; Brancale A; van Kuppeveld FJM
PLoS Biol; 2020 Nov; 18(11):e3000904. PubMed ID: 33156822
[TBL] [Abstract][Full Text] [Related]
16. Drug discovery in enteroviral infections.
Chen TC; Shih SR
Infect Disord Drug Targets; 2011 Jun; 11(3):337-45. PubMed ID: 21488833
[TBL] [Abstract][Full Text] [Related]
17. Replication and Inhibitors of Enteroviruses and Parechoviruses.
van der Linden L; Wolthers KC; van Kuppeveld FJ
Viruses; 2015 Aug; 7(8):4529-62. PubMed ID: 26266417
[TBL] [Abstract][Full Text] [Related]
18. Enteroviral replication inhibition by N-Alkyl triazolopyrimidinone derivatives through a non-capsid binding mode.
Kumar Biswas B; Soo Shin J; Malpani YR; Hwang D; Jung E; Bong Han S; Vishakantegowda AG; Jung YS
Bioorg Med Chem Lett; 2022 May; 64():128673. PubMed ID: 35292344
[TBL] [Abstract][Full Text] [Related]
19. Validating Enterovirus D68-2A
Musharrafieh R; Ma C; Zhang J; Hu Y; Diesing JM; Marty MT; Wang J
J Virol; 2019 Apr; 93(7):. PubMed ID: 30674624
[TBL] [Abstract][Full Text] [Related]
20. Development of broad-spectrum enterovirus antivirals based on quinoline scaffold.
Musharrafieh R; Kitamura N; Hu Y; Wang J
Bioorg Chem; 2020 Aug; 101():103981. PubMed ID: 32559580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
